By
Time for $5 Coalition
Published: Oct. 14, 2021, 5:55 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
Advocates call out Cepheid for canceling commercialization of the portable point-of-care GeneXpert Omni testing instrument and urge the company to reinstate plans to launch Omni, reiterating demands for Cepheid to reduce the price of GeneXpert tests to $5, inclusive of service and maintenance, across diseases.
Read More →
By
Time for $5 Coalition
Published: May 10, 2021, 9:21 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
The Time for $5 Coalition calls out Cepheid for not including price reductions of Xpert tests in their updated GeneXpert pricing packages for low- and middle-income countries.
Read More →